openPR Logo
Press release

Biobanking Market by Sample Type, Application, Storage Type and Forecast Report 2024: P&S Intelligence

04-25-2019 01:53 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: P&S Intelligence

Biobanking Market by Sample Type, Application, Storage Type

The global biobanking market is expected to witness significant growth during the forecast period (2017-2023), on account of impact of various factors such as rise in on-going genomic research of several diseases, technological advancements with respect to biobanking, funding from government and private organizations, and the growing trend of cord blood repository of new born. However, sustaining the biobanks for a long term is a major challenge faced by the biobanking market.

Download free report sample at: https://www.psmarketresearch.com/market-analysis/biobanking-market/report-sample

The biobank market witnesses several drivers for its growth during the forecast period. These include the rise in on-going genomic and proteomic research of several diseases; technological advancement with respect to biobanking processing and storage; funding from government and private organizations to investigate the therapeutic efficacy of regenerative medicines; and the increasing trend of cord blood repository of new born. Moreover, the demand for personalized medication and need to opt for cost effective drug discovery procedures are also driving the growth of the biobanking market worldwide.

The rising technological innovations in the area of cell therapy presents lucrative opportunities for the key players in the biobanking market. Additionally, the unexplored market in the Asia-Pacific region, with countries such as Japan, China, India, provide ample opportunities to the key players to increase their market size and share in biobanking industry.

Pre-Purchase Inquiry at: https://www.psmarketresearch.com/send-enquiry?enquiry-url=biobanking-market

Key companies operating in the global biobanking market are forming partnerships, launching products, and enhancing their product portfolio to strengthen their global presence.

In July 2017, BioLife Solutions, Inc. (BioLife Solutions) announced its supply agreement with Celyad SA for the use of BioLife Solutions’ CryoStor in Natural Killer receptor based T-cell platform to target solid tumours and blood cancer. Earlier, in June 2017, BioLife Solutions announced its supply agreement with Adaptimmune Therapeutics Plc. (Adaptimmune). Under the agreement, BioLife Solutions’ CryoStor clinical grade cell freeze media is to be used in Adaptimmune's manufacturing process for its SPEAR T-cells.

Browse full report at: https://www.psmarketresearch.com/market-analysis/biobanking-market

Some of the major key players operating in the biobanking market include Thermo Fisher Scientific Inc., PHC Holdings Corporation (Panasonic Healthcare Holdings Co. Ltd), Qiagen N.V., Merck KGaA, Brooks Automation. Inc., Hamilton Company, Becton, Dickinson and Company, Greiner Holding AG, BioLife Solutions, Inc., Promega Corporation.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biobanking Market by Sample Type, Application, Storage Type and Forecast Report 2024: P&S Intelligence here

News-ID: 1718293 • Views:

More Releases from P&S Intelligence

Remote Access Provided by Cloud Category Fuels Call Center AI Market
Remote Access Provided by Cloud Category Fuels Call Center AI Market
In 2021, the call center AI market generated sales worth $1,982.9 million, and it is expected to contribute $12,910.6 million in 2030, progressing at a rate of 23.1% from 2021 to 2030, ascribed to the growing up requirements for improved data analytics to manage customer inquiries with the real-time response to improve customer engagement through social media. In order to pace up the 4th industrial revolution, businesses across various industries
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Market
Growing Demand for CSM System Will Drive the Customer Engagement Solutions Marke …
The total value of the customer engagement solutions market was $18,186.8 million in 2021, and it will rise at a growth rate of above 10% in the near future, to reach $43,398.9 million by 2030. The major reasons behind the growth of this industry are growing usage of such solutions in serval industries like healthcare, telecommunications, BFSI and FMCG. North America will grow the fastest with a rate of 10.5% in
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Market
Reduced Operational Cost of Energy Efficient Motors Propels Motion Control Marke …
The motion control market generated a revenue of $14,887.5 million in 2021, and it is expected to contribute $23,286.4 million in 2030, progressing at a rate of 5.1% from 2021 to 2030, ascribed to the rising demand for industrial robots and integration of components with the motion control systems for convenient use. Moreover, the evolving motion control standards and protocols propel the market, for example, the OPC UA TSN protocol controls
North America, the Largest Revenue Producer in Public Safety and Security Market
North America, the Largest Revenue Producer in Public Safety and Security Market
The size of the public safety and security market was at $411 billion in the year 2021, which will reach over $1,115 billion by the year 2030, advancing at a growth rate of around 12% in the years to come. This is largely ascribed to the rising application of innovative technologies in smart cities, increasing crime rates, the increasing cases of disastrous accidents, and the growing count of terrorist activities

All 5 Releases


More Releases for BioLife

Global Organ preservation Market 2020 Business Strategies – BioLife SolutionsI …
The market report titled “Organ preservation Market By Technique (Static Cold Storage, Hypothermic Perfusion Preservation And Other Techniques), By Preservation Solution (Viaspan, Custodiol HTK, Renograf, Perfadex, Human Biosystem (HBS) Solution, Lifor and Others) For Kidney, Lung, Liver, Heart And Other Organs: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022” and published by Zion Market Research will put forth a systematizedevaluation of the vital facets of the global Organ preservation Market
Global Organ preservation Market 2020 Business Strategies – BioLife SolutionsI …
The Zion Market Research added a new report “Organ preservation Market By Technique (Static Cold Storage, Hypothermic Perfusion Preservation And Other Techniques), By Preservation Solution (Viaspan, Custodiol HTK, Renograf, Perfadex, Human Biosystem (HBS) Solution, Lifor and Others) For Kidney, Lung, Liver, Heart And Other Organs: Global Industry Perspective, Comprehensive Analysis and Forecast, 2016-2022” in its database, which provides an expert and in-depth analysis of key business trends and future market
Global Biobanking Market: Top Manufacturers - DNA Genotek, Micronic, Askion, Bio …
Latest industry research report on: Global Biobanking Market : Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Complete Report Details @ http://www.marketresearchreports.biz/analysis/957792 This report studies Global Biobanking market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Beckman Coulter Thermo Fisher
ENovate Biolife reports encouraging results for their Rhinitis Product
ENovate Biolife, a specialty healthcare company, announced new data showing how the company’s lead investigational product E-RH-06 will work for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea. Acute or chronic inflammation of nasal mucous membrane is a hallmark of rhinitis, which may be caused by viruses, bacteria or irritants. The inflammation results in the generation of excessive amounts of mucus, nasal congestion, sneezing and itchiness
ENovate Biolife Targets African Market
Salt Lake City, Utah (Sept 10, 2011) – ENovate Biolife LLC is pleased to announce their participation at Medexpo Kenya 2011 at Nairobi. The Medexpo Kenya will take place on 17-19 September 2011 at Sarit Centre. Medexpo Kenya is the prime event in the region attracting visitors from all over East & Central Africa displaying vast range of products from Hospital Supplies, Medical Equipment, Dental Equipment, Healthcare supplements and Pharmaceuticals.
ENovate Biolife announces start of Clinical Study for Rhinitis
For Immediate Release California, July 20, 2011: ENovate Biolife, a specialty healthcare company, announced today that it has initiated a Phase IIa clinical trial with its lead product E-RH-06 in subjects with Rhinitis. ENovate Biolife has received ethics committee approval for safety and dose determining study for investigational product E-RH-06 for the metabolic management of chronic or recurrent, non-infective nasal congestion with-or-without rhinorrhea. Rhinitis (allergic or non allergic) is a clinical problem